ART-123
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Asahi Kasei Therapeutics Corporation
Overview
ART-123 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
ART-123 clinical trials
Explore related
Medical disclaimer. This page summarizes research about ART-123 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.